A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection. ...
Jan 4, 2024
0
2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rebound occurs at a similar rate for those receiving and not receiving oral antiviral treatment and for those receiving nirmatrelvir/ritonavir or placebo, according ...
Dec 22, 2023
0
0
"COVID rebound," in which evidence of the illness disappears and then returns days or weeks later, is surprisingly common—whether or not patients are given the antiviral Paxlovid.
Mar 3, 2023
0
48
Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not caused by impaired immune responses.
Oct 6, 2022
0
34
Paxlovid and Molnupiravir, two leading COVID-19 antiviral medications, are life-saving drugs that have been shown to reduce deaths, in Paxlovid's case, by a factor of 10 in the most severe cases.
Aug 25, 2022
0
10
After testing positive for COVID-19 last week, First Lady Jill Biden left isolation on Sunday following two negative test results.
Aug 22, 2022
0
15
For many people with COVID, their recovery isn't linear. United States President Joe Biden is one such person—he continues to test positive for SARS-CoV-2, the virus that causes COVID, and has experienced the return of ...
Aug 4, 2022
0
7
President Joe Biden has plenty of company as he experiences a case of rebound COVID-19 after completing a course of the antiviral medication Paxlovid.
Aug 3, 2022
1
6
